PharmaJet to Present Latest Research Showing Superior Immunogenicity with Their Needle-free Systems at Five Conferences in October
Multiple published studies show that needle-free improves vaccine effectiveness GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company who has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that their latest research results will be presented at five upcoming conferences in October: Conference Date City PharmaJet Presenter Vaccines Summit Oct 11-13 Washington, … [Read more…]
